NDATOPICALCREAM
Approved
Sep 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
4/8 — Partial
LOCOID LIPOCREAM (hydrocortisone butyrate) by Precision BioSciences is signaling, immune function, inflammation, and protein regulation; however, the precise mechanism of action in atopic dermatitis is unknown. Approved for atopic dermatitis. First approved in 1997.
Drug data last refreshed 1w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LOCOID LIPOCREAM is a topical corticosteroid cream containing hydrocortisone butyrate approved for atopic dermatitis. It works through signaling, immune function, inflammation, and protein regulation, though the precise mechanism in atopic dermatitis remains unknown. The product is administered as a cream applied directly to affected skin areas.
LOE Approaching
As an approaching LOE product, LOCOID LIPOCREAM faces intensifying generic competition and declining market exclusivity, suggesting smaller brand teams focused on managed care defense and potential asset runoff strategies.
Mechanism of Action
signaling, immune function, inflammation, and protein regulation; however, the precise mechanism of action in atopic dermatitis is unknown.
Indications (1)
Career Relevance
Working on LOCOID LIPOCREAM offers limited career growth and development opportunities, given its LOE-approaching status, zero clinical pipeline, and zero linked job postings. Roles available are primarily defensive commercial positions focused on payer management, market share retention, and competitive pricing rather than product expansion or innovation-driven initiatives.
Worked on LOCOID LIPOCREAM at Precision BioSciences? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.